The Lithotripsy Devices Market is estimated to be valued at USD 1.84 Bn in 2026 and is expected to reach approximately USD 2.61 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2026 to 2033. The market is witnessing steady growth, mainly driven by the rising prevalence of kidney and urinary tract stones, increasing preference for minimally invasive and non-invasive stone-management procedures, and technological advancements in extracorporeal shock wave lithotripsy (ESWL) and intracorporeal lithotripsy systems. Increasing healthcare expenditure, expansion of urology infrastructure, and greater availability of technologically advanced lithotripsy devices are further supporting adoption across hospitals and clinics.

Lithotripsy devices enable the fragmentation and removal of kidney, ureteral, and urinary stones through technologies including laser lithotripsy, electrohydraulic lithotripsy, ultrasonic lithotripsy, mechanical lithotripsy, and extracorporeal shock wave lithotripsy (ESWL). The market is increasingly shifting toward advanced treatment platforms that offer improved stone fragmentation, enhanced procedural efficiency, reduced stone retropulsion, and better stone-clearance outcomes.

Healthcare providers are increasingly focusing on minimally invasive stone-management approaches to reduce patient recovery time and improve procedural outcomes. Rapid advancements in thulium fiber laser (TFL) technology are further transforming intracorporeal lithotripsy by enabling faster fragmentation, lower stone retropulsion, use of smaller laser fibers, and shorter ureteroscopic procedures. Clinical evidence cited in the study also demonstrates improvements in laser time and stone-free outcomes associated with advanced TFL platforms.

Market Dynamics

The market is witnessing significant momentum owing to the growing global burden of urolithiasis, increasing adoption of minimally invasive stone-treatment procedures, and continued technological development in advanced lithotripsy systems. Aging populations, metabolic disorders, obesity, hypertension, dietary changes, and inadequate hydration are contributing to the rising incidence of kidney and urinary stones, thereby increasing the number of patients requiring active stone-removal procedures. This is strengthening demand for extracorporeal shock wave lithotripsy, laser lithotripsy, and other intracorporeal stone-fragmentation systems.

Technological advancement is another major factor influencing market development. The transition from traditional holmium laser systems toward thulium fiber laser platforms is improving fragmentation efficiency, reducing stone retropulsion, and supporting faster ureteroscopic procedures. At the same time, the integration of real-time intrarenal pressure monitoring, suction-enabled ureteral access sheaths, advanced visualization, and stone-evacuation technologies is encouraging the development of more integrated endourology platforms.

The increasing preference for non-invasive treatment is also supporting adoption of extracorporeal shock wave lithotripsy systems. ESWL remains an established treatment option for renal and ureteral stones owing to its avoidance of surgical incisions, relatively short procedure time, and continuing improvements in imaging guidance, shock-wave delivery, and stone targeting. The ESWL system segment is projected to account for approximately 45.5% of the market in 2026.

Hospitals remain the major end users of lithotripsy devices due to the concentration of urologists, operating-room infrastructure, anesthesia capabilities, advanced imaging systems, and availability of multiple stone-treatment modalities. Hospitals are also better equipped to manage complex kidney and ureteral stones, high-risk patients, postoperative complications, and procedures involving ureteroscopy and laser lithotripsy. The hospitals segment is projected to account for approximately 68.5% of the market in 2026.

Regional market development is supported by expanding urology infrastructure and increasing availability of advanced stone-management technologies. North America is projected to account for approximately 41.0% of the global market in 2026, supported by advanced healthcare infrastructure, high utilization of stone-management procedures, and rapid adoption of next-generation laser, suction-assisted, and endourology technologies. Meanwhile, Asia Pacific is expected to be the fastest-growing region owing to its large patient population, expanding hospital and urology infrastructure, and increasing adoption of flexible ureteroscopy and laser lithotripsy procedures.

Key Features of the Study

• This report provides in-depth analysis of the Lithotripsy Devices Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Lithotripsy Devices Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medispec Ltd., Siemens Ltd., Boston Scientific Corporation, Olympus Corporation, Direx Group, Cook Medical, C. R. Bard, Inc., Lumenis, Karl Storz SE & Co. KG, and Dornier MedTech.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Lithotripsy Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Lithotripsy Devices Market

Market Segmentation

• By Device Type (Revenue, USD Bn, 2021-2033)
  • Laser Lithotripsy
  • Electrohydraulic Lithotripsy
  • Ultrasonic Lithotripsy
  • Mechanical Lithotripsy
  • Extracorporeal Shock Wave Lithotripsy (ESWL) System
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Clinics
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Medispec Ltd.
  • Siemens Ltd.
  • Boston Scientific Corporation
  • Olympus Corporation
  • Direx Group
  • Cook Medical
  • R. Bard, Inc.
  • Lumenis
  • Karl Storz SE & Co. KG
  • Dornier MedTech